ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.1
  1. ホーム
  2. /化合物

L-システイン

L-(+)-Cysteine

HCID 5862
反応を作成
印刷

データを補完しています。しばらくしてからページを更新すると最新の内容を表示できます

基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
52-90-4
標準SMILES
N[C@@H](CS)C(=O)O
InChIKey
XUJNEKJLAYXESH-REOHCLBHSA-N
分子式
C3H7NO2S
平均分子量
121.16 g/mol
単同位体質量
121.01974964

概要

L-cysteine is an optically active form of cysteine having L-configuration. It has a role as a flour treatment agent, an EC 4.3.1.3 (histidine ammonia-lyase) inhibitor and a human metabolite. It is a cysteine, a L-alpha-amino acid, a serine family amino acid and a proteinogenic amino acid. It is a conjugate base of a L-cysteinium. It is a conjugate acid of a L-cysteinate(1-). It is an enantiomer of a D-cysteine. It is a tautomer of a L-cysteine zwitterion.

名称と識別子

優先名称
L-(+)-Cysteine
IUPAC
(2R)-2-amino-3-sulfanylpropanoic acid
現地名
L-システイン
英語名
L-Cysteine
分子式
C3H7NO2S
分子量
121.16

名称と別名

L-cysteine52-90-4cysteineCysteinThioserine(R)-2-Amino-3-mercaptopropanoic acidHalf-cystineL-(+)-CysteineL-Cysteinbeta-MercaptoalanineCysteinum(2R)-2-amino-3-sulfanylpropanoic acid
名称をさらに表示
L-システイン(+)-L-システインハイチオールチオセリンシステインL-(+)-システイン(R)-2-アミノ-3-メルカプトプロパン酸(2R)-2-アミノ-3-スルファニルプロパン酸ハーフシスチン(R)-システインエコランハーフシステイン(+)-システインβ-メルカプトアラニンLシステインL‐システインL- システインL-システイン (JP17)システイン3-メルカプトアラニンCYSH-CYS-OHCYSHL-Cys-OHFEMA 3263
L-CyscisteinaHalf cystine2-Amino-3-mercaptopropionic acidL-Alanine, 3-mercapto-FREE CYSTEINECisteinumFEMA No. 3263

物性

構造計算による物性補完中

XLogP
-2.5
極性表面積
64.3 Ų
水素結合供与体数
3
水素結合受容体数
4
回転可能結合数
2
重原子数
7
形式電荷
0
複雑度
75.3

実験および物理化学的性質

Chemical ClassesBiological Agents -> Amino Acids and Derivatives
Drugs · 2 件

Pharmaceuticals -> Listed in ZINC15

Pharmaceuticals -> Metabolite of Acetylcysteine

Cosmetics · 2 件

Cosmetic ingredients (Cysteine) -> CIR (Cosmetic Ingredient Review)

Hair conditioning; Antistatic; Reducing; Antioxidant

Pesticides · 2 件

Agrochemicals -> Pesticide active substances

Active substance -> EU Pesticides database: Approved

LogP · 2 件

log Kow = -2.49

-2.49

Food AdditivesDOUGH STRENGTHENER, FLAVOR ENHANCER, FLAVORING AGENT OR ADJUVANT, FLOUR TREATING AGENT, NUTRIENT SUPPLEMENT -> FDA Substance added to food
Flavoring AgentsEU Flavoring substances
Color/Form · 2 件

Colorless crystals

White crystals

Solubility · 5 件

Freely soluble in water

Freely soluble in alcohol, acetic acid, ammonia water; insoluble in ether, acetone, ethyl acetate, benzene, carbon disulfide, carbon tetrachloride

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

GHS分類

GHS Classification · 6 件

This chemical does not meet GHS hazard criteria for 33.8% (179 of 529) of reports.

Warning

H302 (55.6%): Harmful if swallowed [Warning Acute toxicity, oral]

P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 529 reports by companies from 14 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Warning

危険有害性情報

Regulatory Information · 5 件

Chemical: L-Cysteine

Regulation (EC) No 1831/2003 (amended)

Reg. (EU) 2020/642

REACH registered substance: L-cysteine (EC: 200-158-2)

Cysteine: Does not have an individual approval but may be used under an appropriate group standard

Other Safety InformationIMAP assessments - Cysteine and its salts: Human health tier II assessment
Hazards SummarySafe when used as a flavoring agent in food; [JECFA] May cause irritation; Harmful by ingestion; [Sigma-Aldrich MSDS]
FDA Requirements · 3 件

Cysteine used as a nutrient and/or dietary supplement in animal drugs, feeds, and related products is generally recognized as safe when used in accordance with good manufacturing or feeding practice.

Substance added directly to human food affirmed as generally recognized as safe (GRAS).

The food additive amino acids may be safely used as nutrients added to foods in accordance with the following conditions: (a) The food additive consists of one or more of the following individual amino acids in the free, hydrated, or anhydrous form, or as the hydrochloride, sodium, or potassium salts. L-Cysteine is included on this list.

化学と産業

薬理情報

Bionecessity · 2 件

L-Cysteine is the central compound in sulfur metabolism in the human body. In proteins the formation of disulfide bonds between the thiol groups of cysteine plays an important role for tertiary structure and enzymatic activity ... .

Amino acid catabolism is essential for adjusting pool sizes of free amino acids and takes part in energy production as well as nutrient remobilization. The carbon skeletons are generally converted to precursors or intermediates of the tricarboxylic acid cycle. In the case of cysteine, the reduced sulfur derived from the thiol group also has to be oxidized in order to prevent accumulation to toxic concentrations. ...

Pharmacodynamics · 1 件

Due to this ability to undergo redox reactions, cysteine has antioxidant properties. Cysteine is an important source of sulfur in human metabolism, and although it is classified as a non-essential amino acid, cysteine may be essential for infants, the elderly, and individuals with certain metabolic disease or who suffer from malabsorption syndromes. Cysteine may at some point be recognized as an essential or conditionally essential amino acid.

Mechanism of Action · 1 件

Cysteine can usually be synthesized by the human body under normal physiological conditions if a sufficient quantity of methionine is available. Cysteine is typically synthesized in the human body when there is sufficient methionine available. Cysteine exhibits antioxidant properties and participates in redox reactions. Cysteine's antioxidant properties are typically expressed in the tripeptide glutathione, which occurs in humans as well as other organisms. Glutathione (GSH) typically requires biosynthesis from its constituent amino acids, cysteine, glycine, and glutamic acid, due to its limited systemic availability. Glutamic acid and glycine are readily available in the diets of most industrialized countries, but the availability of cysteine can be the limiting substrate. In human metabolism, cysteine is also involved in the generation of sulfide present in iron-sulfur clusters and nitrogenase by acting as a precursor. In a 1994 report released by five top cigarette companies, cysteine is one of the 599 additives to cigarettes. Its use or purpose, however, is unknown, like most cigarette additives. Its inclusion in cigarettes could offer two benefits: Acting as an expectorant, since smoking increases mucus production in the lungs; and increasing the beneficial antioxidant glutathione (which is diminished in smokers).

関連反応

218 件
反応記録を作成
HRID 1429 の反応式
HRID 1429反応物としてuspto-grants-1998_03
HRID 1929 の反応式
HRID 1929反応物としてuspto-grants-1998_03
HRID 2684 の反応式
HRID 2684反応物としてuspto-grants-1998_03
HRID 19461 の反応式
HRID 19461反応物としてuspto-grants-2010_06
HRID 39120 の反応式
HRID 39120反応物としてuspto-grants-2013_09
HRID 50030 の反応式
HRID 50030反応物としてuspto-grants-2004_03
HRID 58404 の反応式
HRID 58404反応物としてuspto-grants-2016_09
HRID 63202 の反応式
HRID 63202反応物としてuspto-grants-2016_09
前へ1 / 28 ページ

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート

データベース識別子

CAS
52-90-4
PubChem CID
5862
DTXSID
DTXSID8022876
ChEMBL
CHEMBL863
ChEBI
CHEBI:17561
UNII
K848JZ4886
EC Number
200-158-2
Nikkaji
J9.167G

Water solubility (per g/100 g H2O): 28 g/100 mL of solution at 25 °C; 16 g/100 mL of solution at 20 °C

277 mg/mL at 25 °C

Very soluble in water and acetic acid; Insoluble in ether, acetone and benzene

DecompositionWhen heated to decomposition it emits very toxic fumes of /sulfur oxides and nitrogen oxides/.
Melting Point · 2 件

260 °C decomposes

220 °C

Vapor Pressure0.00000207 [mmHg]

物理化学的性質

融点
240 °C · 240 °C (dec.) (lit.)
比旋光度
8.75 · 8.75 º (c=12, 2N HCl)
沸点
293.9 · 293.9±35.0 °C(Predicted)
比重(密度)
1.197 · 1.197 (estimate)
屈折率
8.8 ° · 8.8 ° (C=8, 1mol/L HCl)
FEMA
3263 · 3263 | L-CYSTEINE
貯蔵温度
30 °C · Store below +30°C.
溶解性
2 O: · H2O: 25 mg/mL
外見
個体
酸解離定数(Pka)
1.92 · 1.92(at 25℃)
色
白い
PH
4.5 · 4.5-5.5 (100g/l, H2O, 20℃)
臭い (Odor)
硫黄の
においのタイプ
硫黄の
由来生物
non-animal source
水溶解度
280 g/L · 280g/L(25℃)
Merck
14 · 14,2781
JECFA Number
1419 · 1419
BRN
1721408 · 1721408
安定性
安定性 安定していますが、空気に敏感な場合があります。酸化剤、塩基と相容れない。
化粧品成分の機能
還元剤ヘアコンディショニング香料帯電防止ヘアウェーブとヘアストレート抗酸化物質
InChI
1S/C3H7NO2S/c4-2(1-7)3(5)6/h2,7H,1,4H2,(H,5,6)/t2-/m0/s1
InChIKey
XUJNEKJLAYXESH-REOHCLBHSA-N
SMILES
N[C@@H](CS)C(O)=O
LogP
-2.49 · -2.49
CAS データベース
52 · 52-90-4(CAS DataBase Reference)
NISTの化学物質情報
L-Cysteine(52-90-4)
EPAの化学物質情報
L-Cysteine (52-90-4)
化学的性質 · 2 件

化学的特性システインはアミノ酸の一種であり人体内で重要な役割を果たしていますこの半必須アミノ酸はタンパク質の合成に欠かせない成分であり多くの生理的プロセスに影響を与えることが知られていますシステインの化学式はC3H7NO2Sでその特徴的な構造は多くの生化学的反応においてユニークな役割を果たします

化学的特性A sulfur-containing amino acid, metabolically related to methionine. Methionine is the source of sulfur atom in the synthesis of cysteine in the body. Chemically, L-cysteine is L-2-amino-mercaptopropionic acid. Cysteine has a sulfureous aroma. It is a nutrient and is used in dietary supplements.

FIFRA Requirements · 1 件

Residues of cysteine are exempted from the requirement of a tolerance when used in accordance with good agricultural practice as inert (or occasionally active) ingredients in pesticide formulations applied to growing crops only. Use: Synergist. Limit: Maximum of 0.5% of formulation.

Toxic Combustion ProductsSpecial hazards arising from the substance or mixture: Carbon oxides, nitrogen oxides (NOx), sulphur oxides
Hazard Classes and Categories · 3 件

Acute Tox. 4 (55.6%)

Acute toxicity (ingestion) - category 4

Acute toxicity (Oral) - Category 4

Skin, Eye, and Respiratory Irritations · 3 件

... A single ocular application of the test item L-Cysteine to rabbits at a dose of 0.1 g produced slight irritant effects, which were fully reversible within 48 hours. ...

... The single dermal application of the test item L-Cysteine to three rabbits at a dose of 0.5 g showed neither irritant nor corrosive effects. ...

... Single dermal application of the test item L-Cysteine to rats at a dose of 2000 mg/kg body weight was associated with neither mortality nor signs of toxicity but signs of irritation. ...

Hazardous Reactivities and IncompatibilitiesIncompatible materials: Strong oxidizing agents.

安全と保護具

Fire Fighting Procedures · 2 件

Suitable extinguishing media: Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.

Advice for firefighters: Wear self-contained breathing apparatus for firefighting if necessary.

Storage ConditionsKeep container tightly closed in a dry and well-ventilated place. Store under inert gas. Air sensitive. Storage class (TRGS 510): Non Combustible Solids.
Cleanup Methods · 1 件

ACCIDENTAL RELEASE MEASURES: Personal precautions, protective equipment and emergency procedures: Use personal protective equipment. Avoid dust formation. Avoid breathing vapors, mist or gas. Avoid breathing dust. Environmental precautions: Do not let product enter drains. Methods and materials for containment and cleaning up: Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed containers for disposal.

Disposal Methods · 2 件

SRP: Recycle any unused portion of the material for its approved use or return it to the manufacturer or supplier. Ultimate disposal of the chemical must consider: the material's impact on air quality; potential migration in air, soil or water; effects on animal, aquatic and plant life; and conformance with environmental and public health regulations. If it is possible or reasonable use an alternative chemical product with less inherent propensity for occupational harm/injury/toxicity or environmental contamination.

Product: Offer surplus and non-recyclable solutions to a licensed disposal company; Contaminated packaging: Dispose of as unused product.

Preventive Measures · 5 件

ACCIDENTAL RELEASE MEASURES: Personal precautions, protective equipment and emergency procedures: Use personal protective equipment. Avoid dust formation. Avoid breathing vapors, mist or gas. Avoid breathing dust. Environmental precautions: Do not let product enter drains.

Precautions for safe handling: Further processing of solid materials may result in the formation of combustible dusts. The potential for combustible dust formation should be taken into consideration before additional processing occurs. Provide appropriate exhaust ventilation at places where dust is formed.

Appropriate engineering controls: Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and at the end of workday.

Gloves must be inspected prior to use. Use proper glove removal technique (without touching glove's outer surface) to avoid skin contact with this product. Dispose of contaminated gloves after use in accordance with applicable laws and good laboratory practices. Wash and dry hands.

SRP: Local exhaust ventilation should be applied wherever there is an incidence of point source emissions or dispersion of regulated contaminants in the work area. Ventilation control of the contaminant as close to its point of generation is both the most economical and safest method to minimize personnel exposure to airborne contaminants. Ensure that the local ventilation moves the contaminant away from the worker.

Allowable Tolerances · 1 件

Residues of cysteine are exempted from the requirement of a tolerance when used in accordance with good agricultural practice as inert (or occasionally active) ingredients in pesticide formulations applied to growing crops only. Use: Synergist. Limit: Maximum of 0.5% of formulation.

Personal Protective Equipment (PPE) · 4 件

Eye/face protection: Use equipment for eye protection tested and approved under appropriate government standards such as NIOSH (US) or EN 166(EU).

Skin protection: Handle with gloves.

Body Protection: Choose body protection in relation to its type, to the concentration and amount of dangerous substances, and to the specific work-place. The type of protective equipment must be selected according to the concentration and amount of the dangerous substance at the specific workplace.

Respiratory protection: Respiratory protection is not required. Where protection from nuisance levels of dusts are desired, use type N95 (US) or type P1 (EN 143) dust masks. Use respirators and components tested and approved under appropriate government standards such as NIOSH (US) or CEN (EU).

毒性情報

TreatmentKidney dialysis is usually needed to relieve the symptoms of uremic syndrome until normal kidney function can be restored.
Health EffectsChronic exposure to uremic toxins can lead to a number of conditions including renal damage, chronic kidney disease and cardiovascular disease.
Ecotoxicity Values · 3 件

LD50; Species: Oncorhynchus mykiss (Rainbow trout) weight 30 g; Conditions: freshwater, 15 °C, ip injection; Concentration: 4.5 mmol/kg bw for 4 hr (95% confidence interval: 3.7-5.3 mmol/kg bw) /formulation/

LD50; Species: Oncorhynchus mykiss (Rainbow trout) weight 30 g; Conditions: freshwater, 15 °C, ip injection; Concentration: 4.8 mmol/kg bw for 3 hr (95% confidence interval: 4.5-5.7 mmol/kg bw) /formulation/

LD50; Species: Oncorhynchus mykiss (Rainbow trout) weight 30 g; Conditions: freshwater, 15 °C, ip injection; Concentration: 7.5 mmol/kg bw for 2 hr (95% confidence interval: 6.3-9.6 mmol/kg bw) /formulation/

Environmental Fate · 3 件

TERRESTRIAL FATE: Based on a classification scheme(1), an estimated Koc value of 3(SRC), determined from a structure estimation method(2), indicates that cysteine is expected to have very high mobility in soil(SRC). The pKa values of cysteine are 1.71, 8.33 and 10.78(3), indicating that this compound will exist as a zwitterion in the environment and zwitterions generally adsorb more strongly to soils containing organic carbon and clay than their neutral counterparts(4). Volatilization from moist soil is not expected because the compound exists as an ion and ions do not volatilize. Cysteine is not expected to volatilize from dry soil surfaces(SRC) based upon an estimated vapor pressure of 6.7X10-7 mm Hg at 25 °C(SRC), determined from a fragment constant method(2). Utilizing the Warburg test, 4.7% of the Theoretical BOD was reached in 24 hours(5) indicating that biodegradation is not an important environmental fate process in soil(SRC).

AQUATIC FATE: Based on a classification scheme(1), an estimated Koc value of 3(SRC), determined from a structure estimation method(2), indicates that cysteine is not expected to adsorb to suspended solids and sediment(SRC). The pKa values of 1.71, 8.33 and 10.78(3) indicates cysteine will exist as a zwitterion at pH values of 5 to 9 and, therefore, volatilization from water surfaces is not expected to be an important fate process(SRC). According to a classification scheme(4), an estimated BCF of 3(SRC), from its log Kow of -2.49(5) and a regression-derived equation(2), suggests the potential for bioconcentration in aquatic organisms is low(SRC). Utilizing the Warburg test, 4.7% of the Theoretical BOD was reached in 24 hours(6) indicating that biodegradation is not an important environmental fate process in water(SRC).

ATMOSPHERIC FATE: According to a model of gas/particle partitioning of semivolatile organic compounds in the atmosphere(1), cysteine, which has an estimated vapor pressure of 6.7X10-7 mm Hg at 25 °C(SRC), determined from a fragment constant method(2), will exist in both the vapor and particulate phases in the ambient atmosphere. Vapor-phase cysteine is degraded in the atmosphere by reaction with photochemically-produced hydroxyl radicals(SRC); the half-life for this reaction in air is estimated to be 1.6 hours(SRC), calculated from its rate constant of 8.0X10-11 cu cm/molecule-sec at 25 °C(SRC) that was derived using a structure estimation method(3). Particulate-phase cysteine may be removed from the air by wet and dry deposition(SRC). Cysteine does not contain chromophores that absorb at wavelengths >290 nm(4) and, therefore, is not expected to be susceptible to direct photolysis by sunlight(SRC).

Food Survey ValuesCysteine in fruit juices purchased in supermarkets in Davis, CA(1).[Table#3865]
Exposure RoutesEndogenous, Ingestion, Dermal (contact)
Toxicity Summary · 3 件

Safe in the present practices of use and concentration. Ingredient, concentration, and use information are available in documents discoverable at https://cir-reports.cir-safety.org

IDENTIFICATION AND USE: Cysteine forms white or colorless crystals. It is used in biochemical and nutrition research, as a reducing agent in bread doughs (up to 90 ppm). It is also used as flavor enhancer and medication, including veterinary medication. HUMAN EXPOSURE AND TOXICITY: Cysteine solution (3%) was not irritating for human eyes. ANIMAL STUDIES: A single ocular application of L-cysteine to rabbits at a dose of 0.1 g produced slight irritant effects, which were fully reversible within 48 hours. The single dermal application of L-cysteine to three rabbits at a dose of 0.5 g showed neither irritant nor corrosive effects. Decreased litter size observed in rats receiving high-dose cysteine, which was related to the degeneration and/or death of ovulated unfertilized oocytes and embryos with changes in the zona pellucida, which was already affected in the ovary. Pregnant mice and rats were treated s.c. with 1.2 mg per g on the last day of pregnancy and brain degeneration was observed one day later in the fetus. L-Cysteine is considered to be non-mutagenic in the HPRT locus using V79 cells of the Chinese Hamster. L-Cysteine did not induce structural chromosomal aberrations in the V79 Chinese hamster cell line. ECOTOXICITY STUDIES: The objective of the study was to determine the effects of cysteine on postthaw sperm motility, duration of sperm motility, DNA damage, and fertility in the common carp (Cyprinus carpio). Supplementation with cysteine increased the fertilization and hatching rate and decreased DNA damage.

Uremic toxins such as cysteine are actively transported into the kidneys via organic ion transporters (especially OAT3). Increased levels of uremic toxins can stimulate the production of reactive oxygen species. This seems to be mediated by the direct binding or inhibition by uremic toxins of the enzyme NADPH oxidase (especially NOX4 which is abundant in the kidneys and heart) (A7868). Reactive oxygen species can induce several different DNA methyltransferases (DNMTs) which are involved in the silencing of a protein known as KLOTHO. KLOTHO has been identified as having important roles in anti-aging, mineral metabolism, and vitamin D metabolism. A number of studies have indicated that KLOTHO mRNA and protein levels are reduced during acute or chronic kidney diseases in response to high local levels of reactive oxygen species (A7869). Although classified as a non-essential amino acid cysteine may be essential for infants, the elderly, and individuals with certain metabolic disease or who suffer from malabsorption syndromes. Cysteine can usually be synthesized by the human body under normal physiological conditions if a sufficient quantity of methionine is available. Due to the ability of thiols to undergo redox reactions, cysteine has antioxidant properties. Cysteine's antioxidant properties are typically expressed in the tripeptide glutathione, which occurs in humans as well as other organisms. The systemic availability of oral glutathione (GSH) is negligible; so it must be biosynthesized from its constituent amino acids, cysteine, glycine, and glutamic acid. Glutamic acid and glycine are readily available in the diets of most industrialized countries, but the availability of cysteine can be the limiting substrate. Cysteine is also an important source of sulfide in human metabolism. The sulfide in iron-sulfur clusters and in nitrogenase is extracted from cysteine, which is converted to alanine in the process. In a 1994 report released by five top cigarette companies, cysteine is one of the 599 additives to cigarettes. Its use or purpose, however, is unknown, like most cigarette additives. Its inclusion in cigarettes could offer two benefits: Acting as an expectorant, since smoking increases mucus production in the lungs; and increasing the beneficial antioxidant glutathione (which is diminished in smokers).

Plant ConcentrationsCysteine has been reported in 30 plants(1).[Table#3866]
Signs and Symptoms · 1 件

As a uremic toxin, this compound can cause uremic syndrome. Uremic syndrome may affect any part of the body and can cause nausea, vomiting, loss of appetite, and weight loss. It can also cause changes in mental status, such as confusion, reduced awareness, agitation, psychosis, seizures, and coma. Abnormal bleeding, such as bleeding spontaneously or profusely from a very minor injury can also occur. Heart problems, such as an irregular heartbeat, inflammation in the sac that surrounds the heart (pericarditis), and increased pressure on the heart can be seen in patients with uremic syndrome. Shortness of breath from fluid buildup in the space between the lungs and the chest wall (pleural effusion) can also be present.

Effluent ConcentrationsCysteine was present at 5.0, 1.5 and 0.8 nmol/g in three consecutive horizon samples from an active landfill in a low permeability clay soil, located in Conica-Montemarta, Sevilla, Spain; sampling was conducted following 3 years of use(1).
Soil Adsorption/Mobility · 1 件

Using a structure estimation method based on molecular connectivity indices(1), the Koc of cysteine can be estimated to be 3(SRC). According to a classification scheme(2), this estimated Koc value suggests that cysteine is expected to have very high mobility in soil. The pKa values of cysteine are 1.71, 8.33 and 10.78(3) indicating that this compound will exist as a zwitterion in the environment and zwitterions generally adsorb more strongly to soils containing organic carbon and clay than their neutral counterparts(4).

Natural Pollution SourcesCysteine is a non-essential amino acid for human development(1). Cysteine also occurs in many plants(2).

法規制情報

FDA Requirements · 3 件

Cysteine used as a nutrient and/or dietary supplement in animal drugs, feeds, and related products is generally recognized as safe when used in accordance with good manufacturing or feeding practice.

Substance added directly to human food affirmed as generally recognized as safe (GRAS).

The food additive amino acids may be safely used as nutrients added to foods in accordance with the following conditions: (a) The food additive consists of one or more of the following individual amino acids in the free, hydrated, or anhydrous form, or as the hydrochloride, sodium, or potassium salts. L-Cysteine is included on this list.

FIFRA Requirements · 1 件

Residues of cysteine are exempted from the requirement of a tolerance when used in accordance with good agricultural practice as inert (or occasionally active) ingredients in pesticide formulations applied to growing crops only. Use: Synergist. Limit: Maximum of 0.5% of formulation.

安全データ

F
10-23
wgk
3
tsca
TSCA listed
rtecs
HA1600000
毒性
LD50 orally in Rabbit: 1890 mg/kg
hs_code
29309012
risk_code
22-36/37/38-20/21/22
化審法
(9)-1590 届出不要化学物質
hazard_code
Xn,Xi
safety_code
36-37/39-26-24/25
自然発火温度
420 °C
ストレージクラス
11 - Combustible Solids
有毒物質データの
52-90-4(Hazardous Substances Data)
Metabolism/Metabolites · 3 件

L-Cysteine is the central compound in sulfur metabolism in the human body. In proteins the formation of disulfide bonds between the thiol groups of cysteine plays an important role for tertiary structure and enzymatic activity; cysteine is however always incorporated in the polypeptide chain as cysteine. L-Cysteine is degraded to pyruvate in two steps: one is removal of sulfur and the other is a transamination. Cysteine can be metabolized to form taurine and carbon dioxide through the cysteinsulfinate pathway, where the initial step is oxidation of cysteine to cysteine sulfinate. This step is catalyzed by cysteine dioxygenase. Cysteine sulfinate may then be decarboxylated to form taurine or it may be metabolized via the putative intermediate beta-sulfinylpyruvate to pyruvate and sulfite and then to carbon dioxide and sulfate.

Amino acid catabolism is essential for adjusting pool sizes of free amino acids and takes part in energy production as well as nutrient remobilization. The carbon skeletons are generally converted to precursors or intermediates of the tricarboxylic acid cycle. In the case of cysteine, the reduced sulfur derived from the thiol group also has to be oxidized in order to prevent accumulation to toxic concentrations. Here we present a mitochondrial sulfur catabolic pathway catalyzing the complete oxidation of L-cysteine to pyruvate and thiosulfate. After transamination to 3-mercaptopyruvate the sulfhydryl group from L-cysteine is transferred to glutathione by sulfurtransferase 1 and oxidized to sulfite by the sulfur dioxygenase ETHE1. Sulfite is then converted to thiosulfate by addition of a second persulfide group by sulfurtransferase 1. This pathway is most relevant during early embryo development and for vegetative growth under light limiting conditions. Characterization of a double mutant produced from Arabidopsis thaliana T-DNA insertion lines for ETHE1 and sulfurtransferase 1 revealed that an intermediate of the ETHE1 dependent pathway, most likely a persulfide, interferes with amino acid catabolism and induces early senescence.

Uremic toxins tend to accumulate in the blood either through dietary excess or through poor filtration by the kidneys. Most uremic toxins are metabolic waste products and are normally excreted in the urine or feces.

Tissue LocationsAdrenal Cortex
Cellular LocationsCytoplasm
Metabolite Pathways2-Hydroxyglutric Aciduria (D And L Form)

用途と製造

Uses · 6 件

CIR ingredient: Cysteine

Cysteine is a non-essential amino acid that has been used as a dough conditioner and veterinary detoxicant; [Merck Index] Used as a flavoring agent, dough strengthener, nutritional supplement, and flour treating agent for foods; [FDA] Used for biochemical and nutritional research and as a medication; [HSDB]

Reported uses (ppm):

Biochemical and nutrition research, reducing agent in bread doughs (up to 90 ppm).

MEDICATION

MEDICATION (VET)

U.S. ProductionNon-confidential 2012 Chemical Data Reporting (CDR) information on the production and use of chemicals manufactured or imported into the United States. Chemical: L-Cysteine. National Production Volume: 28,660 lb/yr.
Methods of Manufacturing · 2 件

By addition of a thiol compound to an unsaturated amino acid derivative; by hydrolysis of proteins in the presence of carbon dioxide; by treating in HCl hydrolysis of proteins in the presence of carbon dioxide; by treating an HCl hydrolysate of hair with CuO2, followed by the decomposition of the resulting copper-cysteine complex with hydrogen sulfide; by the addition of thioacetic acid to alpha-acetamido acrylic acid; by treatment of a keratine HCl hydrolysate with zinc to reduce the cystine present to cysteine; by electrolytic reduction of cystine.

L-Cysteine used to be produced almost exclusively by hydrolysis of hair or other keratins. The amino acid isolated was l-cystine, which was reduced electrolytically to l-cysteine. L-Cysteine has also been prepared from beta-chloro-d,l-alanine and sodium sulfide with cysteine desulfhydrase, an enzyme obtained from, e.g., Citrobacterium freundii. Today, however, the main processes for cysteine production are biological. A direct fermentation process has been developed for the manufacture of l-cystine, using a modified Escherichia coli bacterium. The technology has been extended to prepare other modified l-cysteine analogues. An enzymatic process for l-cysteine has been successfully developed using microorganisms capable to hydrolyze 2-amino-delta2-thiazoline 4-carboxylic acid (ATC) which is readily available from methyl alpha-chloroacrylate and thiourea. A mutant of Pseudomonas thiazolinophilum converts d,l-ATC to l-cysteine in 95% molar yield at product concentrations higher than 30 g/L.

Formulations/PreparationsAvailable commercially as L(+)-cysteine hydrochloride.
Household ProductsInformation on 4 consumer products that contain Cysteine in the following categories is provided:
Use Classification · 3 件

Flavouring Agent -> FLAVOURING_AGENT -> JECFA Functional Classes

Flavoring Agents -> JECFA Flavorings Index

Cosmetics -> Hair conditioning; Antistatic; Reducing; Antioxidant

General Manufacturing Information · 3 件

L-Cysteine: ACTIVE

A non-essential amino acid in human development.

An amino acid derived from cystine, occurring naturally in the L-form ...

応用分野 · 8 件

解説天然のR(L)形は分解点178 ℃.[α]25D-16.5°(水).pK1 1.71,pK2 8.33,pK3 10.78.水,エタノール,氷酢酸,アンモニア水に易溶,ほかの有機溶媒に難溶.微量の金属の存在下ではとくに不安定で,空気酸化されてシスチンにかわる.解毒剤や食用補剤に用いられる.LD50 1890 mg/kg(ラット,経口).森北出版「化学辞典(第2版)

用途化粧品、食品の添加物、酸化防止剤

用途SH 基を有する化合物です。 粘液ムコタンパクのジスルフィド結合を解離 する作用を示します。

用途SH 基を有する化合物です。 粘液ムコタンパクのジスルフィド結合を解離 する作用を示します。

説明Cysteine (abbreviated as Cys or C) is an α-amino acid with the chemical formula HO2CCH(NH2)CH2SH. It is a semi - essential amino acid, which means that it can be biosynthesized in humans. The thiol side chain in cysteine often participates in enzymatic reactions, serving as a nucleophile. The thiol is susceptible to oxidization to give the disulfide derivative cystine, which serves an important structural role in many proteins. When used as a food additive, it has the E number E920.

天然物の起源Dietary sources Although classified as a non-essential amino acid, in rare cases, cysteine may be essential for infants, the elderly, and individuals with certain metabolic disease or who suffer from malabsorption syndromes. Cysteine can usually be synthesized by the human body under normal physiological conditions if a sufficient quantity of methionine is available. Cysteine is catabolized in the gastrointestinal tract and blood plasma. In contrast, cystine travels safely through the GI tract and blood plasma and is promptly reduced to the two cysteine molecules upon cell entry. Industrial sources The majority of L - cysteine is obtained industrially by hydrolysis of poultry feathers or human hair. Synthetically produced L-cysteine, compliant with Jewish Kosher and Muslim Halal rules, is also available, albeit at a higher price. The synthetic route involves fermentation utilizing a mutant of E. coli. Biosynthesis In animals, biosynthesis begins with the amino acid serine. The sulfur is derived from methionine, which is converted to homocysteine through the intermediate S- adenosylmethionine. Cystathionine betasynthase then combines homocysteine and serine to form the asymmetrical thioether cystathionine. The enzyme cystathionine gamma-lyase converts the cystathionine into cysteine and alphaketobutyrate.

使用L-Cysteine is a non-essential amino acid that can be synthesized by the human body under normal physiological conditions if a sufficient quantity of methionine is available. L-Cysteine is commonly used as a precursor in the food and pharmaceutical industries. L-Cysteine is used as a processing aid for baking, as an additive in cigarettes, as well as in the preparation of meat flavours. It is used in foods to prevent oxygen from destroying vitamin c and is used in doughs to reduce mixing time.

一般的な説明L-cysteine is a sulfur-containing non-essential amino acid. Its ability to reduce colitis symptoms is being assessed for potential use in treating inflammatory bowel disease (IBD).

調製方法 · 2 件

製造方法L-Cysteine used to be produced almost exclusively by hydrolysis of hair or other keratins. The amino acid isolated was l-cystine, which was reduced electrolytically to l-cysteine. L-Cysteine has also been prepared from beta-chloro-d,l-alanine and sodium sulfide with cysteine desulfhydrase, an enzyme obtained from, e.g., Citrobacterium freundii. Today, however, the main processes for cysteine production are biological. A direct fermentation process has been developed for the manufacture of l-cystine, using a modified Escherichia coli bacterium. The technology has been extended to prepare other modified l-cysteine analogues. An enzymatic process for l-cysteine has been successfully developed using microorganisms capable to hydrolyze 2-amino-delta2-thiazoline 4-carboxylic acid (ATC) which is readily available from methyl alpha-chloroacrylate and thiourea. A mutant of Pseudomonas thiazolinophilum converts d,l-ATC to l-cysteine in 95% molar yield at product concentrations higher than 30 g/L.

純化方法Purify it by recrystallisation from H2O (free from metal ions) and dry it in a vacuum. It is soluble in H2O, EtOH, Me2CO, EtOAc, AcOH, *C6H6 and CS2. Acidic solutions can be stored under N2 for a few days without deterioration. [For synthesis and spectra see Greenstein & Winitz Chemistry of the Amino Acids (J. Wiley) Vol 3 p1879 1961, Beilstein 4 III 1618, 4 IV 3144.]

上流・下流製品情報

上流原料

ジヒドリド硫黄アンモニア水タンパク質Cystine hydrochlorideL-(-)-シスチンTin granularDilute hydrochloric acid

下流製品

Chiral 2,2-Disubstituted thiaprolinol derivativesN-アセチル-L-システインビオチンカルボシステイン6-(ブロモメチル)-2,4-プテリジンジアミン臭化水素酸塩ラニチジンパパインL-システイン·塩酸塩S-(カルボキシメチル)-L-システイン3,3,5,5-テトラメチル-1,2,4-トリチオランL-システイン塩酸塩一水和物1,2,5,6-TetrathiocaneS-(2-ヒドロキシエチル)-L-システインジエンコル酸
補足説明 · 2 件

定義本品は、次の化学式で表されるアミノ酸である。

定義ChEBI: L-cysteine is an optically active form of cysteine having L-configuration. It has a role as a flour treatment agent, a human metabolite and an EC 4.3.1.3 (histidine ammonia-lyase) inhibitor. It is a serine family amino acid, a proteinogenic amino acid, a cysteine and a L-alpha-amino acid. It is a conjugate base of a L-cysteinium. It is a conjugate acid of a L-cysteinate(1-). It is an enantiomer of a D-cysteine. It is a tautomer of a L-cysteine zwitterion.